» Articles » PMID: 2127350

Cloning and Characterization of a DNA Fragment That Confers Sulfonamide Resistance in a Serogroup B, Serotype 15 Strain of Neisseria Meningitidis

Overview
Specialty Pharmacology
Date 1990 Nov 1
PMID 2127350
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

By cloning studies and complementation experiments, the sulfonamide resistance gene of a serogroup B and serotype 15 (B:15) strain of Neisseria meningitidis was localized to a 1.2-kb chromosomal SspI fragment expressing a drug-resistant dihydropteroate synthase. The fragment hybridized to DNA from both resistant and susceptible strains, suggesting that the resistance gene is a variant of the normal gene for dihydropteroate synthase.

Citing Articles

Genealogical typing of Neisseria meningitidis.

Didelot X, Urwin R, Maiden M, Falush D Microbiology (Reading). 2009; 155(Pt 10):3176-3186.

PMID: 19643763 PMC: 2762044. DOI: 10.1099/mic.0.031534-0.


Variations in gene organization and DNA uptake signal sequence in the folP region between commensal and pathogenic Neisseria species.

Qvarnstrom Y, Swedberg G BMC Microbiol. 2006; 6:11.

PMID: 16503987 PMC: 1431543. DOI: 10.1186/1471-2180-6-11.


Mutations in folP associated with elevated sulfonamide MICs for Neisseria meningitidis clinical isolates from five continents.

Fiebelkorn K, Crawford S, Jorgensen J Antimicrob Agents Chemother. 2005; 49(2):536-40.

PMID: 15673729 PMC: 547345. DOI: 10.1128/AAC.49.2.536-540.2005.


Molecular techniques for the investigation of meningococcal disease epidemiology.

Maiden M, Frosch M Mol Biotechnol. 2001; 18(2):119-34.

PMID: 11471454 DOI: 10.1385/MB:18:2:119.


Antibiotic susceptibility patterns of Neisseria meningitidis isolates from patients and asymptomatic carriers.

Arreaza L, de la Fuente L, Vazquez J Antimicrob Agents Chemother. 2000; 44(6):1705-7.

PMID: 10817734 PMC: 89938. DOI: 10.1128/AAC.44.6.1705-1707.2000.


References
1.
Dowd J, Blink D, Miller C, FRANK P, PIERCE W . Antibiotic prophylaxis of carriers of sulfadiazine-resistant meningococci. J Infect Dis. 1966; 116(4):473-80. DOI: 10.1093/infdis/116.4.473. View

2.
SKOLD O . R-factor-mediated resistance to sulfonamides by a plasmid-borne, drug-resistant dihydropteroate synthase. Antimicrob Agents Chemother. 1976; 9(1):49-54. PMC: 429472. DOI: 10.1128/AAC.9.1.49. View

3.
Andersen B . Mortality in meningococcal infections. Scand J Infect Dis. 1978; 10(4):277-82. DOI: 10.3109/inf.1978.10.issue-4.04. View

4.
BOVRE K . Epidemiological patterns of meningococcal disease in Norway 1975-1979. NIPH Ann. 1980; 3(2):9-22. View

5.
BOVRE K, Froholm L, Gaustad P, Holten E, Hoiby E . Some agent characteristics and their coexistence related to occurrence and severity of systemic meningococcal disease in Norway, Winter 1981-1982. NIPH Ann. 1983; 6(1):75-84. View